Jianjun Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jianjun Zheng has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
Qi Dai
Radiology Department, Ningbo No.2 Hospital, Ningbo, 315010, China
6 shared publicationsJingfeng Zhang
Radiology Department, Ningbo No.2 Hospital, Ningbo, 315010, China
5 shared publications- Jingfeng Zhang
Department of Radiology, Ningbo No. 2 Hospital, China
5 shared publications - Aiguo Wu
Chinese Academy of Sciences
3 shared publications Chunshu Pan
Department of Radiology, Ningbo No.2 Hospital, Ningbo, 315012, China
3 shared publicationsWei Sun
Department of Radiology, Ningbo No.2 Hospital, Ningbo, 315012, China
3 shared publications
Latest Publications
- Open Access
- 9 April 2026
- Published by Springer Nature in BMC Medical Imaging
- Vol. 26 (1)
Development and evaluation of multi-strategy fusion machine learning models for predicting postoperative recurrence in non-small cell lung cancer
We developed multiple machine learning models using various fusion strategies to predict the risk of recurrence within three years post-surgery in non-small cell lung cancer (NSCLC) patients. Our aim was to enhance the accuracy of prognostic predictions and assess the differences and effectiveness of these fusion strategies. We retrospectively included 306 patients with histologically confirmed NSCLC who underwent curative surgical resection. Preoperative clinical variables and CT-based radiomic features were extracted for analysis. Radiomic features were harmonized using the ComBat method to mitigate scanner-related variability. Feature selection was performed within a nested five-fold cross-validation framework, and features consistently selected in at least three inner folds were retained. Six predictive models were developed, including a clinical model, a radiomics model, an early fusion model, two intermediate fusion models (feature-level fusion and radiomics score (Radscore)-level fusion), and a late fusion model. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, and F1-score. Model discrimination was compared using DeLong’s test, and SHAP analysis was applied to enhance model interpretability. Among all developed models, fusion-based approaches consistently outperformed unimodal models. The Radscore-level fusion model demonstrated the best discriminative performance, achieving the highest cross-validated AUC of 0.864, followed closely by the feature-level fusion model (AUC = 0.860). Both intermediate fusion models significantly outperformed the clinical model and showed superior discrimination compared with the radiomics model. The early fusion and late fusion models yielded comparable but relatively lower performance. DeLong test results confirmed that the Radscore-level fusion model significantly outperformed the clinical, radiomics, early fusion, and late fusion models. SHAP analysis further illustrated the relative importance and directional effects of key clinical and radiomic features contributing to model predictions. Multiple fusion strategies are feasible and effective for predicting postoperative recurrence in patients with NSCLC. Among them, the feature-level fusion approach maintains favorable predictive performance while offering improved interpretability, supporting its potential utility for postoperative recurrence risk stratification. The online version contains supplementary material available at 10.1186/s12880-026-02328-w.
- 9 April 2026
- Published by Springer Nature in BMC Medical Imaging
- Vol. 26 (1)
Open AccessDevelopment and evaluation of multi-strategy fusion machine learning models for predicting postoperative recurrence in non-small cell lung cancer
We developed multiple machine learning models using various fusion strategies to predict the risk of recurrence within three years post-surgery in non-small cell lung cancer (NSCLC) patients. Our aim was to enhance the accuracy of prognostic predictions and assess the differences and effectiveness of these fusion strategies. We retrospectively included 306 patients with histologically confirmed NSCLC who underwent curative surgical resection. Preoperative clinical variables and CT-based radiomic features were extracted for analysis. Radiomic features were harmonized using the ComBat method to mitigate scanner-related variability. Feature selection was performed within a nested five-fold cross-validation framework, and features consistently selected in at least three inner folds were retained. Six predictive models were developed, including a clinical model, a radiomics model, an early fusion model, two intermediate fusion models (feature-level fusion and radiomics score (Radscore)-level fusion), and a late fusion model. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, and F1-score. Model discrimination was compared using DeLong’s test, and SHAP analysis was applied to enhance model interpretability. Among all developed models, fusion-based approaches consistently outperformed unimodal models. The Radscore-level fusion model demonstrated the best discriminative performance, achieving the highest cross-validated AUC of 0.864, followed closely by the feature-level fusion model (AUC = 0.860). Both intermediate fusion models significantly outperformed the clinical model and showed superior discrimination compared with the radiomics model. The early fusion and late fusion models yielded comparable but relatively lower performance. DeLong test results confirmed that the Radscore-level fusion model significantly outperformed the clinical, radiomics, early fusion, and late fusion models. SHAP analysis further illustrated the relative importance and directional effects of key clinical and radiomic features contributing to model predictions. Multiple fusion strategies are feasible and effective for predicting postoperative recurrence in patients with NSCLC. Among them, the feature-level fusion approach maintains favorable predictive performance while offering improved interpretability, supporting its potential utility for postoperative recurrence risk stratification. The online version contains supplementary material available at 10.1186/s12880-026-02328-w.
- Open Access
Association between abdominal CT-based body composition parameters and early diabetic kidney disease in type 2 diabetes mellitus: a retrospective cross-sectional study
Background: Early identification of diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM) remains challenging due to limitations of conventional biomarkers. Body composition analysis using computed tomography (CT) may provide novel insights into DKD risk stratification. Objective: To investigate the association between abdominal CT-based body composition parameters and early diagnosis of DKD in patients with T2DM. Methods: This retrospective cohort study enrolled 310 patients with T2DM from the Second Hospital of Ningbo between January 2020 and December 2024. Patients were stratified into the early DKD group ( n = 131) and the T2DM control group without DKD ( n = 179) based on the results of renal function assessment. Using Slice-O-Matic software, we measured area, index, and radiodensity of skeletal muscle and adipose tissue depots at the L3 vertebral level on abdominal CT images. Spearman correlation analysis evaluated associations between body composition parameters and renal function indicators. Univariate and multivariate logistic regression analyses identified independent risk factors for the development of early DKD. Receiver operating characteristic (ROC) curve analysis was employed to assess the predictive value of body composition parameters for early DKD. Results: Multivariate logistic regression analysis revealed four independent risk factors of early DKD. Age (OR = 1.03, 95% CI [1.01–1.06], P = 0.044), high-sensitivity C-reactive protein (OR = 1.02, 95% CI [1.01–1.04], P = 0.005), renal sinus fat index (OR = 0.50, 95% CI [0.30–0.85], P = 0.010), and renal sinus fat density (OR = 0.79, 95% CI [0.74–0.85], P < 0.001). Multiple linear regression analysis demonstrated that renal sinus fat density maintained significant associations with both the urinary albumin-to-creatinine ratio (β = −1.88, P < 0.001) and the estimated glomerular filtration rate (β = 0.22, P = 0.017) after adjusting for confounding variables. The combined clinical-body composition model (AUC = 0.81, 95% CI [0.76–0.86]) and the body composition-only model (AUC = 0.77, 95% CI [0.72–0.82]) both demonstrated superior predictive performance compared to the clinical-only model (AUC = 0.67, 95% CI [0.61–0.73]). Conclusions: Reduced renal sinus fat density is significantly associated with early DKD in T2DM patients, demonstrating potential utility as an imaging biomarker for risk stratification. These findings support the integration of CT-based body composition analysis into comprehensive DKD screening strategies.
Open AccessAssociation between abdominal CT-based body composition parameters and early diabetic kidney disease in type 2 diabetes mellitus: a retrospective cross-sectional study
Background: Early identification of diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM) remains challenging due to limitations of conventional biomarkers. Body composition analysis using computed tomography (CT) may provide novel insights into DKD risk stratification. Objective: To investigate the association between abdominal CT-based body composition parameters and early diagnosis of DKD in patients with T2DM. Methods: This retrospective cohort study enrolled 310 patients with T2DM from the Second Hospital of Ningbo between January 2020 and December 2024. Patients were stratified into the early DKD group ( n = 131) and the T2DM control group without DKD ( n = 179) based on the results of renal function assessment. Using Slice-O-Matic software, we measured area, index, and radiodensity of skeletal muscle and adipose tissue depots at the L3 vertebral level on abdominal CT images. Spearman correlation analysis evaluated associations between body composition parameters and renal function indicators. Univariate and multivariate logistic regression analyses identified independent risk factors for the development of early DKD. Receiver operating characteristic (ROC) curve analysis was employed to assess the predictive value of body composition parameters for early DKD. Results: Multivariate logistic regression analysis revealed four independent risk factors of early DKD. Age (OR = 1.03, 95% CI [1.01–1.06], P = 0.044), high-sensitivity C-reactive protein (OR = 1.02, 95% CI [1.01–1.04], P = 0.005), renal sinus fat index (OR = 0.50, 95% CI [0.30–0.85], P = 0.010), and renal sinus fat density (OR = 0.79, 95% CI [0.74–0.85], P < 0.001). Multiple linear regression analysis demonstrated that renal sinus fat density maintained significant associations with both the urinary albumin-to-creatinine ratio (β = −1.88, P < 0.001) and the estimated glomerular filtration rate (β = 0.22, P = 0.017) after adjusting for confounding variables. The combined clinical-body composition model (AUC = 0.81, 95% CI [0.76–0.86]) and the body composition-only model (AUC = 0.77, 95% CI [0.72–0.82]) both demonstrated superior predictive performance compared to the clinical-only model (AUC = 0.67, 95% CI [0.61–0.73]). Conclusions: Reduced renal sinus fat density is significantly associated with early DKD in T2DM patients, demonstrating potential utility as an imaging biomarker for risk stratification. These findings support the integration of CT-based body composition analysis into comprehensive DKD screening strategies.
- Open Access
- 26 December 2025
- Published by Springer Nature in European Spine Journal
- Vol. 35 (8) , 1-9
Posture-dependent assessment of whole-spine curvature with a rotatable cryogen-free 1.5T MRI and automated Cobb angle analysis
- 26 December 2025
- Published by Springer Nature in European Spine Journal
- Vol. 35 (8) , 1-9
Open AccessPosture-dependent assessment of whole-spine curvature with a rotatable cryogen-free 1.5T MRI and automated Cobb angle analysis
- Open Access
- 20 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (D1) , D239-D246
NONCODE v7.0: updated lncRNA resource integrating scRNA-seq data encompassing immune baseline, development, and disease
The rapid advancement of single-cell multi-omics technologies, typified by single-cell RNA sequencing (scRNA-seq), has provided systematic methodologies for dissecting gene expression heterogeneity within cell populations. However, long noncoding RNAs (lncRNAs) research is hindered by a lack of databases covering diverse tissues, disease contexts, and integrated multi-dimensional single-cell annotations. To address this gap, we updated NONCODE v7.0 (available at https://v7.noncode.org/) through the integration of scRNA-seq data, enabling systematic analysis of lncRNA expression. NONCODE v7.0 incorporates 2061 human scRNA-seq samples from 229 datasets, covering a spectrum of 6 categories, with 3 core ones including Physiological Control as an immune baseline, Physiological Development, and Pathological Disease. Following standardized quality control and processing, the database encompasses 14 million high-quality cells and annotates 94 843 lncRNAs (98.5% of human lncRNAs in NONCODE v6.0). Furthermore, we extended the database through the integration of single-cell-tailored functional modules, encompassing data query and retrieval, interactive visualization (including cell composition, UMAP/t-SNE clustering, marker gene heatmaps, and lncRNA expression profiles), and comparative analysis functionalities. The analytical module facilitates the identification of cell-type-specific differentially expressed (DE) lncRNAs across distinct disease states, thus establishing a foundational resource platform to facilitate the advancement of downstream functional investigations into lncRNAs.
- 20 November 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (D1) , D239-D246
Open AccessNONCODE v7.0: updated lncRNA resource integrating scRNA-seq data encompassing immune baseline, development, and disease
The rapid advancement of single-cell multi-omics technologies, typified by single-cell RNA sequencing (scRNA-seq), has provided systematic methodologies for dissecting gene expression heterogeneity within cell populations. However, long noncoding RNAs (lncRNAs) research is hindered by a lack of databases covering diverse tissues, disease contexts, and integrated multi-dimensional single-cell annotations. To address this gap, we updated NONCODE v7.0 (available at https://v7.noncode.org/) through the integration of scRNA-seq data, enabling systematic analysis of lncRNA expression. NONCODE v7.0 incorporates 2061 human scRNA-seq samples from 229 datasets, covering a spectrum of 6 categories, with 3 core ones including Physiological Control as an immune baseline, Physiological Development, and Pathological Disease. Following standardized quality control and processing, the database encompasses 14 million high-quality cells and annotates 94 843 lncRNAs (98.5% of human lncRNAs in NONCODE v6.0). Furthermore, we extended the database through the integration of single-cell-tailored functional modules, encompassing data query and retrieval, interactive visualization (including cell composition, UMAP/t-SNE clustering, marker gene heatmaps, and lncRNA expression profiles), and comparative analysis functionalities. The analytical module facilitates the identification of cell-type-specific differentially expressed (DE) lncRNAs across distinct disease states, thus establishing a foundational resource platform to facilitate the advancement of downstream functional investigations into lncRNAs.
- Top Cited PapersOpen Access
- 18 July 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1626906
Radiation exposure in recurrent medical imaging: identifying drivers and high-risk populations
Medical imaging modalities constitute indispensable diagnostic and therapeutic decision-making tools in contemporary clinical practice. These modalities are pivotal in disease detection, longitudinal monitoring, and treatment response assessment. However, the progressive accumulation of radiation exposure from recurrent imaging procedures has sparked significant clinical concerns regarding potential carcinogenic and non-carcinogenic health implications. This review analyzes the driving factors of recurrent medical imaging examinations, identifies high-risk populations, and evaluates the potential health risks associated with cumulative radiation exposure, aiming to optimize imaging techniques and dose management strategies. By integrating global radiation exposure data (e.g., UNSCEAR reports) and multicenter clinical research evidence combined with a literature review and dosimetry models, the study reveals the high-risk nature of emergency department patients, chronic disease patients, children, and female populations in recurrent imaging. Clinical needs, demographic characteristics, technological misuse, and uneven healthcare resource allocation are identified as key drivers of recurrent imaging. This review further highlights that short-term, high-frequency imaging accelerates cumulative radiation dose accumulation, potentially elevating long-term health risks, while long-term, low-dose exposure is associated with cardiovascular diseases and malignancies. Based on the linear no-threshold (LNT) model and evidence of DNA repair mechanisms, the study proposes individualized risk assessment to optimize imaging intervals and dose modulation techniques to balance diagnostic efficacy and radiation safety. The policy implications of this research include advocating for enhanced radiation safety education and targeted management strategies for high-risk populations and providing empirical support for updating international radiation protection guidelines, thereby facilitating the clinical implementation of the “As Low As Reasonably Achievable” (ALARA) principle.
- 18 July 2025
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1626906
Top Cited PapersOpen AccessRadiation exposure in recurrent medical imaging: identifying drivers and high-risk populations
Medical imaging modalities constitute indispensable diagnostic and therapeutic decision-making tools in contemporary clinical practice. These modalities are pivotal in disease detection, longitudinal monitoring, and treatment response assessment. However, the progressive accumulation of radiation exposure from recurrent imaging procedures has sparked significant clinical concerns regarding potential carcinogenic and non-carcinogenic health implications. This review analyzes the driving factors of recurrent medical imaging examinations, identifies high-risk populations, and evaluates the potential health risks associated with cumulative radiation exposure, aiming to optimize imaging techniques and dose management strategies. By integrating global radiation exposure data (e.g., UNSCEAR reports) and multicenter clinical research evidence combined with a literature review and dosimetry models, the study reveals the high-risk nature of emergency department patients, chronic disease patients, children, and female populations in recurrent imaging. Clinical needs, demographic characteristics, technological misuse, and uneven healthcare resource allocation are identified as key drivers of recurrent imaging. This review further highlights that short-term, high-frequency imaging accelerates cumulative radiation dose accumulation, potentially elevating long-term health risks, while long-term, low-dose exposure is associated with cardiovascular diseases and malignancies. Based on the linear no-threshold (LNT) model and evidence of DNA repair mechanisms, the study proposes individualized risk assessment to optimize imaging intervals and dose modulation techniques to balance diagnostic efficacy and radiation safety. The policy implications of this research include advocating for enhanced radiation safety education and targeted management strategies for high-risk populations and providing empirical support for updating international radiation protection guidelines, thereby facilitating the clinical implementation of the “As Low As Reasonably Achievable” (ALARA) principle.
- Open Access
- 22 March 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101692
Artificial intelligence-assisted magnetic resonance lymphography for evaluation of micro- and macro-sentinel lymph node metastasis in breast cancer
- 22 March 2025
- Published by Elsevier in Materials Today Bio
- Vol. 32, 101692
Open AccessArtificial intelligence-assisted magnetic resonance lymphography for evaluation of micro- and macro-sentinel lymph node metastasis in breast cancer
- 20 March 2025
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (8) , 869-881
Advances in the treatment of atherosclerotic plaque based on nanomaterials
Atherosclerosis is the leading cause of cardiovascular disease worldwide, posing not only a significant threat to cardiovascular health but also impairing the function of multiple organs, with severe cases potentially being life-threatening. Consequently, the effective treatment of atherosclerosis is of paramount importance in reducing the mortality associated with cardiovascular diseases. With the advancement of nanomedicine and a deeper understanding of the pathological mechanisms underlying atherosclerosis, nanomaterials have emerged as promising platforms for precise diagnosis and targeted therapeutic strategies. These materials offer notable advantages, including targeted drug delivery, enhanced bioavailability, improved drug stability, and controlled release. This review provides an overview of the mechanisms underlying atherosclerotic plaque development and examines nanomaterial-based therapeutic approaches for managing atherosclerotic plaques, including therapies targeting cholesterol metabolism, anti-inflammatory strategies, macrophage clearance, and immunotherapy. Additionally, the paper discusses the current technical challenges associated with the clinical transformation of these therapies. Finally, the potential future integration of nanomaterials, smart nanomaterials, and artificial intelligence in the treatment of atherosclerosis is also explored.
- 20 March 2025
- Published by Taylor & Francis in Nanomedicine
- Vol. 20 (8) , 869-881
Advances in the treatment of atherosclerotic plaque based on nanomaterials
Atherosclerosis is the leading cause of cardiovascular disease worldwide, posing not only a significant threat to cardiovascular health but also impairing the function of multiple organs, with severe cases potentially being life-threatening. Consequently, the effective treatment of atherosclerosis is of paramount importance in reducing the mortality associated with cardiovascular diseases. With the advancement of nanomedicine and a deeper understanding of the pathological mechanisms underlying atherosclerosis, nanomaterials have emerged as promising platforms for precise diagnosis and targeted therapeutic strategies. These materials offer notable advantages, including targeted drug delivery, enhanced bioavailability, improved drug stability, and controlled release. This review provides an overview of the mechanisms underlying atherosclerotic plaque development and examines nanomaterial-based therapeutic approaches for managing atherosclerotic plaques, including therapies targeting cholesterol metabolism, anti-inflammatory strategies, macrophage clearance, and immunotherapy. Additionally, the paper discusses the current technical challenges associated with the clinical transformation of these therapies. Finally, the potential future integration of nanomaterials, smart nanomaterials, and artificial intelligence in the treatment of atherosclerosis is also explored.
- Open Access
Quantitative evaluation of muscle mass based on chest high-resolution CT and its prognostic value for tuberculosis: a retrospective study
Objective: This study aims to explore the prognostic value of quantitatively evaluating muscle mass using chest high resolution computed tomography (HRCT) in patients with active tuberculosis (TB). Methods: This retrospective cohort study collected data from 309 patients with active TB diagnosed at Ningbo No.2 Hospital from 2020 to 2023. Based on the skeletal muscle index (SMI) at the T12 vertebra (with thresholds of 2/m2 for men and 2/m2 for women), patients were divided into a low muscle mass group and a normal muscle mass group. The study compared baseline characteristics, muscle mass-related indicators, body mass index (BMI), and imaging features between the two groups. The correlation between muscle mass-related indicators, BMI, and TB imaging features and prognosis was analyzed. Receiver operating characteristic (ROC) curve analysis and multivariate logistic regression were used to assess the prognostic value of muscle mass-related indicators and BMI in patients undergoing anti-TB treatment. Results: A total of 309 patients were included in the study, divided into a normal muscle mass group (n = 229) and a low muscle mass group (n = 80). There was a significant difference in prognosis between the two groups (χ2 test, p < 0.05). Patients in the low muscle mass group were older, had a higher proportion of males, and had a lower BMI (p < 0.05). Additionally, these patients had a higher likelihood of developing pulmonary cavities (p < 0.05). In terms of imaging features, the two groups showed significant differences in the pre-treatment proportion of pulmonary fibrotic bands, ground-glass opacities, consolidation, lesion percentage, and lesion absorption ratio (all p < 0.05). Univariate analysis indicated that both the T12 skeletal muscle index (T12 SMI) and BMI were correlated with TB imaging characteristics (p < 0.05), with T12 SMI showing a stronger correlation than BMI. Multivariable linear regression analysis revealed that after adjusting for age, gender, and T12 skeletal muscle radiation attenuation (T12 SMRA), T12 SMI remained significantly correlated with the whole-lung lesion proportion (β: − 4.56, 95% CI [−5.45 to −3.67]) and lesion absorption ratio (β:0.036, 95% CI [0.031–0.041]). Multivariable logistic regression analysis demonstrated that after accounting for age, gender, T12 SMRA, T12 SMI was significantly associated with the prognosis of TB patients (OR: 20.10, 95% CI [8.81–51.56], p < 0.05), indicating that low T12 SMI is an independent risk factor associated with poor prognosis. ROC curve analysis indicated that T12 SMI may offer advantages over BMI, with an area under the ROC curve (AUC) of T12 SMI (0.761, 95% CI [0.690–0.832]) higher than the AUC of BMI (0.700, 95% CI [0.619–0.781]. Conclusion: Quantitative evaluation of muscle mass using chest HRCT, particularly the T12 SMI, may provide valuable prognostic information for tuberculosis patients, potentially offering advantages over BMI in assessing patient outcomes.
Open AccessQuantitative evaluation of muscle mass based on chest high-resolution CT and its prognostic value for tuberculosis: a retrospective study
Objective: This study aims to explore the prognostic value of quantitatively evaluating muscle mass using chest high resolution computed tomography (HRCT) in patients with active tuberculosis (TB). Methods: This retrospective cohort study collected data from 309 patients with active TB diagnosed at Ningbo No.2 Hospital from 2020 to 2023. Based on the skeletal muscle index (SMI) at the T12 vertebra (with thresholds of 2/m2 for men and 2/m2 for women), patients were divided into a low muscle mass group and a normal muscle mass group. The study compared baseline characteristics, muscle mass-related indicators, body mass index (BMI), and imaging features between the two groups. The correlation between muscle mass-related indicators, BMI, and TB imaging features and prognosis was analyzed. Receiver operating characteristic (ROC) curve analysis and multivariate logistic regression were used to assess the prognostic value of muscle mass-related indicators and BMI in patients undergoing anti-TB treatment. Results: A total of 309 patients were included in the study, divided into a normal muscle mass group (n = 229) and a low muscle mass group (n = 80). There was a significant difference in prognosis between the two groups (χ2 test, p < 0.05). Patients in the low muscle mass group were older, had a higher proportion of males, and had a lower BMI (p < 0.05). Additionally, these patients had a higher likelihood of developing pulmonary cavities (p < 0.05). In terms of imaging features, the two groups showed significant differences in the pre-treatment proportion of pulmonary fibrotic bands, ground-glass opacities, consolidation, lesion percentage, and lesion absorption ratio (all p < 0.05). Univariate analysis indicated that both the T12 skeletal muscle index (T12 SMI) and BMI were correlated with TB imaging characteristics (p < 0.05), with T12 SMI showing a stronger correlation than BMI. Multivariable linear regression analysis revealed that after adjusting for age, gender, and T12 skeletal muscle radiation attenuation (T12 SMRA), T12 SMI remained significantly correlated with the whole-lung lesion proportion (β: − 4.56, 95% CI [−5.45 to −3.67]) and lesion absorption ratio (β:0.036, 95% CI [0.031–0.041]). Multivariable logistic regression analysis demonstrated that after accounting for age, gender, T12 SMRA, T12 SMI was significantly associated with the prognosis of TB patients (OR: 20.10, 95% CI [8.81–51.56], p < 0.05), indicating that low T12 SMI is an independent risk factor associated with poor prognosis. ROC curve analysis indicated that T12 SMI may offer advantages over BMI, with an area under the ROC curve (AUC) of T12 SMI (0.761, 95% CI [0.690–0.832]) higher than the AUC of BMI (0.700, 95% CI [0.619–0.781]. Conclusion: Quantitative evaluation of muscle mass using chest HRCT, particularly the T12 SMI, may provide valuable prognostic information for tuberculosis patients, potentially offering advantages over BMI in assessing patient outcomes.
- Open Access
- 25 February 2025
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1493259
Case Report: Fatal atrioesophageal fistula following atrial fibrillation ablation—critical reflections on prevention
Radiofrequency ablation (RFA) is an important therapeutic modality for atrial fibrillation (AF), widely utilized in clinical practice due to its safety and significant efficacy. However, post-procedural complications may arise, influenced by anatomical positioning and the intensity of ablation energy, with atrioesophageal fistula (AEF) being particularly rare yet severe. This case report describes a unique instance of a patient developing AEF following AF ablation, accompanied by ischemic stroke and myocardial infarction. A 71-year-old male admitted to the emergency department on July 19, 2024, with acute loss of consciousness and convulsions. Upon admission, physical examination and laboratory tests revealed vital signs within abnormal ranges and indicators suggesting inflammation and potential myocardial injury. Head CT scans showed hypoattenuating areas indicative of cerebral infarction, chest CT suggested possible air accumulation in the left atrial region. ECG findings were consistent with atrial flutter, myocardial infarction, and incomplete right bundle branch block. Given his history of atrial fibrillation and RFA, alongside clinical manifestations, the patient was diagnosed with cardio-cerebral syndrome, suspected to be complicated by an AEF due to the presence of air in the left atrium. AEF diagnosis was confirmed via cardiac CTA, leading to conservative management decisions. Despite initiating thrombolysis for cerebral infarction and supportive treatments for heart failure, including VA-ECMO, the patient's condition continued to decline, evidenced by cardiogenic shock, heart failure, and progressive neurological deficits including coma and dilated non-reactive pupils. Ultimately resulting in family-elected discharge against medical advice on the fourth day of hospitalization.
- 25 February 2025
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 12, 1493259
Open AccessCase Report: Fatal atrioesophageal fistula following atrial fibrillation ablation—critical reflections on prevention
Radiofrequency ablation (RFA) is an important therapeutic modality for atrial fibrillation (AF), widely utilized in clinical practice due to its safety and significant efficacy. However, post-procedural complications may arise, influenced by anatomical positioning and the intensity of ablation energy, with atrioesophageal fistula (AEF) being particularly rare yet severe. This case report describes a unique instance of a patient developing AEF following AF ablation, accompanied by ischemic stroke and myocardial infarction. A 71-year-old male admitted to the emergency department on July 19, 2024, with acute loss of consciousness and convulsions. Upon admission, physical examination and laboratory tests revealed vital signs within abnormal ranges and indicators suggesting inflammation and potential myocardial injury. Head CT scans showed hypoattenuating areas indicative of cerebral infarction, chest CT suggested possible air accumulation in the left atrial region. ECG findings were consistent with atrial flutter, myocardial infarction, and incomplete right bundle branch block. Given his history of atrial fibrillation and RFA, alongside clinical manifestations, the patient was diagnosed with cardio-cerebral syndrome, suspected to be complicated by an AEF due to the presence of air in the left atrium. AEF diagnosis was confirmed via cardiac CTA, leading to conservative management decisions. Despite initiating thrombolysis for cerebral infarction and supportive treatments for heart failure, including VA-ECMO, the patient's condition continued to decline, evidenced by cardiogenic shock, heart failure, and progressive neurological deficits including coma and dilated non-reactive pupils. Ultimately resulting in family-elected discharge against medical advice on the fourth day of hospitalization.
- Open Access
Association between a healthy lifestyle and the prevalence of depression in radiology residents in China: findings from a nationwide survey
Objective The relationship between a healthy lifestyle and depression in radiology residents remains poorly understood. This study aims to investigate the relationship between a healthy lifestyle and depressive symptoms in radiology residents in a nationwide survey. Design Cross-sectional study. Setting The survey was conducted among radiology residents undergoing training in China between December 2020 and April 2021. This encompassed a total of 215 municipalities and 406 training centres. Participants 3677 radiology residents in 31 provinces of China. Primary and secondary outcome measures The primary outcome was Healthy Lifestyle Score (HLS). A multiple logistic regression analysis was performed to evaluate the association between lifestyle factors and depressive symptoms. Additionally, the weighted quantile sum (WQS) index was utilised to identify the lifestyle factor that had the greatest impact on depressive symptoms. Results The study sample consisted of 3677 participants, among whom the prevalence of depression was 34.7%. Participants were categorised based on their Health Lifestyle Score (HLS) into three groups: low HLS (LHLS), moderate HLS (MHLS) and high HLS (HHLS), with proportions of 8.0%, 79.8% and 12.2%, respectively. Those with LHLS were found to have a significantly higher risk of depression (OR: 5.21, 95% CI: 3.72 to 7.30) and a more severe level of depression (p for trendConclusion The study establishes a significant association between an LHLS (long and irregular work hours) and an elevated risk of depressive symptoms among the participants, emphasising the crucial role of sleep in this relationship. These findings underline the importance of promoting a healthy lifestyle, specifically emphasising the need for adequate sleep, among radiology residents.
Open AccessAssociation between a healthy lifestyle and the prevalence of depression in radiology residents in China: findings from a nationwide survey
Objective The relationship between a healthy lifestyle and depression in radiology residents remains poorly understood. This study aims to investigate the relationship between a healthy lifestyle and depressive symptoms in radiology residents in a nationwide survey. Design Cross-sectional study. Setting The survey was conducted among radiology residents undergoing training in China between December 2020 and April 2021. This encompassed a total of 215 municipalities and 406 training centres. Participants 3677 radiology residents in 31 provinces of China. Primary and secondary outcome measures The primary outcome was Healthy Lifestyle Score (HLS). A multiple logistic regression analysis was performed to evaluate the association between lifestyle factors and depressive symptoms. Additionally, the weighted quantile sum (WQS) index was utilised to identify the lifestyle factor that had the greatest impact on depressive symptoms. Results The study sample consisted of 3677 participants, among whom the prevalence of depression was 34.7%. Participants were categorised based on their Health Lifestyle Score (HLS) into three groups: low HLS (LHLS), moderate HLS (MHLS) and high HLS (HHLS), with proportions of 8.0%, 79.8% and 12.2%, respectively. Those with LHLS were found to have a significantly higher risk of depression (OR: 5.21, 95% CI: 3.72 to 7.30) and a more severe level of depression (p for trendConclusion The study establishes a significant association between an LHLS (long and irregular work hours) and an elevated risk of depressive symptoms among the participants, emphasising the crucial role of sleep in this relationship. These findings underline the importance of promoting a healthy lifestyle, specifically emphasising the need for adequate sleep, among radiology residents.